Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
DNA Cell Biol. 2012 Apr;31(4):553-9. doi: 10.1089/dna.2011.1364. Epub 2011 Sep 23.
The aim of the current study was to examine the influence of interaction between polymorphisms of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C with angiotensin converting enzyme insertion/deletion (ACE I/D) polymorphism on the risk of diabetic nephropathy (DN). In a case control study using polymerase chain reaction (PCR)- and PCR-restriction fragment length polymorphism (RFLP), the presence of three polymorphisms in 140 patients with type 2 diabetes mellitus (T2DM) with nephropathy including patients with micro- and macro-albuminuria and 72 patients with normoalbuminuria from Western Iran were investigated. In the presence of both MTHFR 677 T and ACE D alleles, there was a trend toward increased risk of DN 2.68-fold (p=0.054). The possession of both MTHFR 677 T and ACE D alleles increased the risk of macro-albuminuria four times (p=0.035). The concomitant presence of both MTHFR 1298 C and ACE D alleles increased the risk of macro-albuminuria 7.8-fold (p=0.012). In addition, the risk of progression from micro- to macro-albuminuria in the presence of both alleles tended to be increased (4.1-fold, p=0.09). Our study for the first time demonstrated a synergistic effect between ACE I/D with either MTHFR C677T or A1298C polymorphism on the increased risk of DN among patients with T2DM. We found that MTHFR 1298 C strongly interacts with the ACE D allele and augments the risk of DN in our population.
本研究旨在探讨亚甲基四氢叶酸还原酶(MTHFR)C677T 和 A1298C 与血管紧张素转换酶插入/缺失(ACE I/D)多态性之间的相互作用对糖尿病肾病(DN)风险的影响。在一项病例对照研究中,使用聚合酶链反应(PCR)和 PCR-限制性片段长度多态性(RFLP),对来自伊朗西部的 140 例 2 型糖尿病(T2DM)合并肾病患者(包括微量白蛋白尿和大量白蛋白尿患者)和 72 例正常白蛋白尿患者的三种多态性进行了研究。在同时存在 MTHFR 677 T 和 ACE D 等位基因的情况下,DN 的风险呈增加趋势,约为 2.68 倍(p=0.054)。同时携带 MTHFR 677 T 和 ACE D 等位基因使发生大量白蛋白尿的风险增加了四倍(p=0.035)。同时携带 MTHFR 1298 C 和 ACE D 等位基因使发生大量白蛋白尿的风险增加了 7.8 倍(p=0.012)。此外,在同时存在两种等位基因的情况下,从微量白蛋白尿进展为大量白蛋白尿的风险也呈增加趋势(4.1 倍,p=0.09)。本研究首次表明,ACE I/D 与 MTHFR C677T 或 A1298C 多态性之间存在协同作用,增加了 T2DM 患者发生 DN 的风险。我们发现,MTHFR 1298 C 与 ACE D 等位基因强烈相互作用,在我们的人群中增加了 DN 的风险。